J. Derek Lewis & Associates Inc.
Source: SEC Form 13F · as of Mar 2026J. Derek Lewis & Associates Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $21.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$21.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for AbbVie Inc. (ABBV)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 37,431 | $8.3M |
| ABTABBOTT LABORATORIES | 31,649 | $3.6M |
| LLYELI LILLY & Co | 2,230 | $2.2M |
| BMYBRISTOL MYERS SQUIBB CO | 18,414 | $1.1M |
| JNJJOHNSON & JOHNSON | 4,219 | $978K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,271 | $950K |
| GILDGILEAD SCIENCES, INC. | 5,840 | $767K |
| MCKMcKesson Corporation | 707 | $597K |
| AMGNAMGEN INC | 1,656 | $562K |
| CORCencora Inc. | 1,560 | $508K |
| MRKMerck & Co., Inc. | 4,063 | $458K |
| UPXIUPEXI, INC. | 249,000 | $351K |
| FRMMFORUM MARKETS Inc | 66,000 | $265K |
| PMPhilip Morris International Inc | 1,387 | $222K |
| PYXSPyxis Oncology, Inc. | 96,000 | $124K |
| VIVOMERIDIAN BIOSCIENCE INC | 20,000 | $45K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.